Determinants Used to Justify the Strength of Recommendations among Korean Clinical Practice Guidelines

A standardized systematic approach to grade evidence and the strength of recommendations is important for guideline users to minimize bias and help interpret the most suitable decisions at the point of care. The study aims to identify and classify determinants used to make judgement for the strength...

Full description

Saved in:
Bibliographic Details
Published inJournal of Korean medical science Vol. 33; no. 8; pp. e79 - 55
Main Authors Shin, Ein-Soon, Jang, Ji-Eun, Yeon, Ji-Yun, Kim, Da-sol, Chang, Sung-Goo, Lee, Yoon-Seong
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Academy of Medical Sciences 19.02.2018
대한의학회
Subjects
Online AccessGet full text
ISSN1011-8934
1598-6357
1598-6357
DOI10.3346/jkms.2018.33.e79

Cover

Loading…
Abstract A standardized systematic approach to grade evidence and the strength of recommendations is important for guideline users to minimize bias and help interpret the most suitable decisions at the point of care. The study aims to identify and classify determinants used to make judgement for the strength of recommendations among 56 Korean clinical practice guidelines (CPGs), and explore strong recommendations based on low quality of evidence. Determinants used in the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach among 34 CPGs which have reported both strength of recommendations and level of evidence were reviewed. Five of 34 CPGs (14.7%) considered quality of evidence, benefits and harms, patients' values and preferences, and costs. And 24 of 34 CPGs (70.6%) considered both magnitude of effect and feasibility as additional determinants. Judgement table was not widely provided for use to translate evidence into recommendations. Eighty-two of 121 recommendations (67.8%, ranged 20.0% to 100.0%) among 11 CPGs using the same judgement scheme showed 'strong' strength of recommendations based on low or very low quality of evidence. Among 5 paradigmatic situations that justify strong recommendations based on low or very low evidence, situation classified as 'potential equivalence, one option clearly less risky or costly' was 87.8% for 82 strong recommendations. Situation classified as 'uncertain benefit, certain harm' was 4.9%. There is a need to introduce and systematize an evidence-based grading system. Using judgement table to justify the strength of recommendations and applying the 5 paradigmatic situations mentioned above is also recommended in the near future.
AbstractList A standardized systematic approach to grade evidence and the strength of recommendations is important for guideline users to minimize bias and help interpret the most suitable decisions at the point of care. The study aims to identify and classify determinants used to make judgement for the strength of recommendations among 56 Korean clinical practice guidelines (CPGs), and explore strong recommendations based on low quality of evidence.BACKGROUNDA standardized systematic approach to grade evidence and the strength of recommendations is important for guideline users to minimize bias and help interpret the most suitable decisions at the point of care. The study aims to identify and classify determinants used to make judgement for the strength of recommendations among 56 Korean clinical practice guidelines (CPGs), and explore strong recommendations based on low quality of evidence.Determinants used in the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach among 34 CPGs which have reported both strength of recommendations and level of evidence were reviewed.METHODSDeterminants used in the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach among 34 CPGs which have reported both strength of recommendations and level of evidence were reviewed.Five of 34 CPGs (14.7%) considered quality of evidence, benefits and harms, patients' values and preferences, and costs. And 24 of 34 CPGs (70.6%) considered both magnitude of effect and feasibility as additional determinants. Judgement table was not widely provided for use to translate evidence into recommendations. Eighty-two of 121 recommendations (67.8%, ranged 20.0% to 100.0%) among 11 CPGs using the same judgement scheme showed 'strong' strength of recommendations based on low or very low quality of evidence. Among 5 paradigmatic situations that justify strong recommendations based on low or very low evidence, situation classified as 'potential equivalence, one option clearly less risky or costly' was 87.8% for 82 strong recommendations. Situation classified as 'uncertain benefit, certain harm' was 4.9%.RESULTSFive of 34 CPGs (14.7%) considered quality of evidence, benefits and harms, patients' values and preferences, and costs. And 24 of 34 CPGs (70.6%) considered both magnitude of effect and feasibility as additional determinants. Judgement table was not widely provided for use to translate evidence into recommendations. Eighty-two of 121 recommendations (67.8%, ranged 20.0% to 100.0%) among 11 CPGs using the same judgement scheme showed 'strong' strength of recommendations based on low or very low quality of evidence. Among 5 paradigmatic situations that justify strong recommendations based on low or very low evidence, situation classified as 'potential equivalence, one option clearly less risky or costly' was 87.8% for 82 strong recommendations. Situation classified as 'uncertain benefit, certain harm' was 4.9%.There is a need to introduce and systematize an evidence-based grading system. Using judgement table to justify the strength of recommendations and applying the 5 paradigmatic situations mentioned above is also recommended in the near future.CONCLUSIONThere is a need to introduce and systematize an evidence-based grading system. Using judgement table to justify the strength of recommendations and applying the 5 paradigmatic situations mentioned above is also recommended in the near future.
A standardized systematic approach to grade evidence and the strength of recommendations is important for guideline users to minimize bias and help interpret the most suitable decisions at the point of care. The study aims to identify and classify determinants used to make judgement for the strength of recommendations among 56 Korean clinical practice guidelines (CPGs), and explore strong recommendations based on low quality of evidence. Determinants used in the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach among 34 CPGs which have reported both strength of recommendations and level of evidence were reviewed. Five of 34 CPGs (14.7%) considered quality of evidence, benefits and harms, patients' values and preferences, and costs. And 24 of 34 CPGs (70.6%) considered both magnitude of effect and feasibility as additional determinants. Judgement table was not widely provided for use to translate evidence into recommendations. Eighty-two of 121 recommendations (67.8%, ranged 20.0% to 100.0%) among 11 CPGs using the same judgement scheme showed 'strong' strength of recommendations based on low or very low quality of evidence. Among 5 paradigmatic situations that justify strong recommendations based on low or very low evidence, situation classified as 'potential equivalence, one option clearly less risky or costly' was 87.8% for 82 strong recommendations. Situation classified as 'uncertain benefit, certain harm' was 4.9%. There is a need to introduce and systematize an evidence-based grading system. Using judgement table to justify the strength of recommendations and applying the 5 paradigmatic situations mentioned above is also recommended in the near future.
Background: A standardized systematic approach to grade evidence and the strength of recommendations is important for guideline users to minimize bias and help interpret the most suitable decisions at the point of care. The study aims to identify and classify determinants used to make judgement for the strength of recommendations among 56 Korean clinical practice guidelines (CPGs), and explore strong recommendations based on low quality of evidence. Methods: Determinants used in the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach among 34 CPGs which have reported both strength of recommendations and level of evidence were reviewed. Results: Five of 34 CPGs (14.7%) considered quality of evidence, benefits and harms, patients' values and preferences, and costs. And 24 of 34 CPGs (70.6%) considered both magnitude of effect and feasibility as additional determinants. Judgement table was not widely provided for use to translate evidence into recommendations. Eighty-two of 121 recommendations (67.8%, ranged 20.0% to 100.0%) among 11 CPGs using the same judgement scheme showed ‘strong’ strength of recommendations based on low or very low quality of evidence. Among 5 paradigmatic situations that justify strong recommendations based on low or very low evidence, situation classified as ‘potential equivalence, one option clearly less risky or costly’ was 87.8% for 82 strong recommendations. Situation classified as ‘uncertain benefit, certain harm’ was 4.9%. Conclusion: There is a need to introduce and systematize an evidence-based grading system. Using judgement table to justify the strength of recommendations and applying the 5 paradigmatic situations mentioned above is also recommended in the near future. KCI Citation Count: 0
Author Yeon, Ji-Yun
Lee, Yoon-Seong
Jang, Ji-Eun
Shin, Ein-Soon
Chang, Sung-Goo
Kim, Da-sol
AuthorAffiliation 1 Research Agency for Clinical Practice Guidelines, Research Center, Korean Academy of Medical Sciences, Seoul, Korea
3 Department of Urology, Kyung Hee University School of Medicine, Seoul, Korea
4 Department of Forensic Medicine, Seoul National University College of Medicine, Seoul, Korea
2 Department of Medical Sciences, Ewha Womans University Graduate School, Seoul, Korea
AuthorAffiliation_xml – name: 4 Department of Forensic Medicine, Seoul National University College of Medicine, Seoul, Korea
– name: 3 Department of Urology, Kyung Hee University School of Medicine, Seoul, Korea
– name: 1 Research Agency for Clinical Practice Guidelines, Research Center, Korean Academy of Medical Sciences, Seoul, Korea
– name: 2 Department of Medical Sciences, Ewha Womans University Graduate School, Seoul, Korea
Author_xml – sequence: 1
  givenname: Ein-Soon
  orcidid: 0000-0002-5086-6086
  surname: Shin
  fullname: Shin, Ein-Soon
  organization: Research Agency for Clinical Practice Guidelines, Research Center, Korean Academy of Medical Sciences, Seoul, Korea
– sequence: 2
  givenname: Ji-Eun
  orcidid: 0000-0002-0691-0289
  surname: Jang
  fullname: Jang, Ji-Eun
  organization: Department of Medical Sciences, Ewha Womans University Graduate School, Seoul, Korea
– sequence: 3
  givenname: Ji-Yun
  orcidid: 0000-0002-6029-910X
  surname: Yeon
  fullname: Yeon, Ji-Yun
  organization: Research Agency for Clinical Practice Guidelines, Research Center, Korean Academy of Medical Sciences, Seoul, Korea
– sequence: 4
  givenname: Da-sol
  orcidid: 0000-0002-2498-699X
  surname: Kim
  fullname: Kim, Da-sol
  organization: Research Agency for Clinical Practice Guidelines, Research Center, Korean Academy of Medical Sciences, Seoul, Korea
– sequence: 5
  givenname: Sung-Goo
  orcidid: 0000-0003-0733-7266
  surname: Chang
  fullname: Chang, Sung-Goo
  organization: Department of Urology, Kyung Hee University School of Medicine, Seoul, Korea
– sequence: 6
  givenname: Yoon-Seong
  orcidid: 0000-0002-1899-3632
  surname: Lee
  fullname: Lee, Yoon-Seong
  organization: Department of Forensic Medicine, Seoul National University College of Medicine, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29441759$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002315226$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1UUtvEzEQtlARfcCdE_IRDhvWr31ckKpAS6ESqLRny_aOEze7drG9lfrvcZIWARKnmfF8D3m-Y3TggweEXpN6wRhv3t9uprSgNenKuIC2f4aOiOi7qmGiPSh9TUjV9YwfouOUbuuaCkHZC3RIe85JK_ojZD9Chjg5r3xO-CbBgHPAX-aUnX3AeQ34R47gV3mNg8VXYMI0gR9UdsEnrKbgV_hriKA8Xo7OO6NG_D0qk50BfD67AcorpJfouVVjgleP9QTdnH26Xn6uLr-dXyxPLyvDWZ0ravnAhdVaD0IbpqETjWKM0a7VwDVnmnIwvaAtNJSCKJ-lmpNOUdu2arDsBL3b6_po5cY4GZTb1VWQmyhPr64vJG0Y5YQV7Ic99m7WEwwGfI5qlHfRTSo-7Jh_b7xbF517Kbq6b0VTBN4-CsTwc4aU5eSSgXFUHsKcJC0Hp6QloivQN396_TZ5CqIAmj3AxJBSBCuNy7srF2s3SlLLbeJym7jcJl5GWRIvxPof4pP2fym_AJSOsYc
CitedBy_id crossref_primary_10_1111_jep_14264
crossref_primary_10_1111_jep_14274
Cites_doi 10.1016/j.jclinepi.2014.10.011
10.1016/j.jclinepi.2015.09.006
10.1016/j.jclinepi.2010.07.015
10.1016/j.jclinepi.2013.09.020
10.1016/j.jclinepi.2013.02.003
10.1136/bmj.39504.506319.80
10.1177/1077558712461283
10.1136/bmj.39490.551019.BE
10.1016/j.jclinepi.2013.02.004
10.1016/j.jclinepi.2011.12.007
10.1016/j.jclinepi.2014.11.006
10.1164/rccm.200602-197ST
10.1136/bmj.39493.646875.AE
10.1016/j.jclinepi.2012.04.012
10.1136/bmj.328.7454.1490
10.1136/bmj.39489.470347.AD
10.1016/j.jclinepi.2012.01.006
10.1136/adc.2010.199307
10.5124/jkma.2011.54.7.758
10.4103/1817-1737.146849
10.1186/1472-6963-5-25
10.1016/j.jclinepi.2012.03.013
10.1111/j.1398-9995.2010.02530.x
10.1111/j.1398-9995.2009.01973.x
10.1371/journal.pmed.1000094
10.1016/j.jclinepi.2010.04.026
10.1186/1472-6963-4-38
10.1016/j.jclinepi.2015.11.017
ContentType Journal Article
Copyright 2018 The Korean Academy of Medical Sciences.
2018 The Korean Academy of Medical Sciences. 2018 The Korean Academy of Medical Sciences
Copyright_xml – notice: 2018 The Korean Academy of Medical Sciences.
– notice: 2018 The Korean Academy of Medical Sciences. 2018 The Korean Academy of Medical Sciences
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.3346/jkms.2018.33.e79
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1598-6357
EndPage 55
ExternalDocumentID oai_kci_go_kr_ARTI_2632413
PMC5809756
29441759
10_3346_jkms_2018_33_e79
Genre Journal Article
GroupedDBID ---
29K
2WC
3O-
5-W
53G
5GY
8JR
8XY
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EF.
EJD
F5P
FRP
GROUPED_DOAJ
GX1
HYE
KQ8
M48
O5R
O5S
OK1
OVT
PGMZT
RNS
RPM
TR2
W2D
XSB
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c430t-2f4d45fbbbd5bc3be856a333287be4b43b24ec9527e622e51592b418a2f77adf3
IEDL.DBID M48
ISSN 1011-8934
1598-6357
IngestDate Sun Mar 09 07:54:37 EDT 2025
Thu Aug 21 18:19:54 EDT 2025
Thu Jul 10 17:09:59 EDT 2025
Mon Jul 21 06:03:55 EDT 2025
Thu Apr 24 23:01:37 EDT 2025
Tue Jul 01 01:44:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Quality of Evidence
Clinical Practice Guidelines
Judgement Table
GRADE Approach
Strength of Recommendations
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c430t-2f4d45fbbbd5bc3be856a333287be4b43b24ec9527e622e51592b418a2f77adf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Ein-Soon Shin and Ji-Eun Jang contributed equally to this work.
ORCID 0000-0002-2498-699X
0000-0003-0733-7266
0000-0002-5086-6086
0000-0002-0691-0289
0000-0002-1899-3632
0000-0002-6029-910X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2018.33.e79
PMID 29441759
PQID 2002217158
PQPubID 23479
PageCount 13
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_2632413
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5809756
proquest_miscellaneous_2002217158
pubmed_primary_29441759
crossref_citationtrail_10_3346_jkms_2018_33_e79
crossref_primary_10_3346_jkms_2018_33_e79
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-Feb-19
PublicationDateYYYYMMDD 2018-02-19
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-Feb-19
  day: 19
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of Korean medical science
PublicationTitleAlternate J Korean Med Sci
PublicationYear 2018
Publisher The Korean Academy of Medical Sciences
대한의학회
Publisher_xml – name: The Korean Academy of Medical Sciences
– name: 대한의학회
References Schünemann (10.3346/jkms.2018.33.e79_ref11) 2006; 174
Mustafa (10.3346/jkms.2018.33.e79_ref6) 2013; 66
Andrews (10.3346/jkms.2018.33.e79_ref14) 2013; 66
Korean Academy of Medical Sciences (10.3346/jkms.2018.33.e79_ref40) 2013
Brozek (10.3346/jkms.2018.33.e79_ref17) 2009; 64
Atkins (10.3346/jkms.2018.33.e79_ref5) 2005; 5
Guyatt (10.3346/jkms.2018.33.e79_ref18) 2011; 64
Brunetti (10.3346/jkms.2018.33.e79_ref23) 2013; 66
Neumann (10.3346/jkms.2018.33.e79_ref25) 2016; 72
Guyatt (10.3346/jkms.2018.33.e79_ref19) 2013; 66
Guyatt (10.3346/jkms.2018.33.e79_ref21) 2008; 336
Korean Pancreatobiliary Association (10.3346/jkms.2018.33.e79_ref37) 2013
The Korean Academy of Tuberculosis and Respiratory Diseases (10.3346/jkms.2018.33.e79_ref30) 2012
Fraenkel (10.3346/jkms.2018.33.e79_ref22) 2013; 70
Atkins (10.3346/jkms.2018.33.e79_ref16) 2004; 328
Alexander (10.3346/jkms.2018.33.e79_ref27) 2016; 72
Korean Academy of Medical Sciences (10.3346/jkms.2018.33.e79_ref36) 2012
The Korean Academy of Tuberculosis and Respiratory Diseases (10.3346/jkms.2018.33.e79_ref38) 2014
The Korean Association for the Study of the Liver (10.3346/jkms.2018.33.e79_ref34) 2011
Guyatt (10.3346/jkms.2018.33.e79_ref12) 2008; 336
Thornton (10.3346/jkms.2018.33.e79_ref8) 2013; 66
Korean Academy of Medical Sciences (10.3346/jkms.2018.33.e79_ref31) 2012
The Korean Academy of Tuberculosis and Respiratory Diseases (10.3346/jkms.2018.33.e79_ref33) 2014
Andrews (10.3346/jkms.2018.33.e79_ref13) 2013; 66
Brożek (10.3346/jkms.2018.33.e79_ref15) 2011; 66
Atkins (10.3346/jkms.2018.33.e79_ref2) 2004; 4
Kavanagh (10.3346/jkms.2018.33.e79_ref10) 2009; 6
Nasser (10.3346/jkms.2018.33.e79_ref7) 2015; 68
Cuello García (10.3346/jkms.2018.33.e79_ref1) 2011; 96
Guyatt (10.3346/jkms.2018.33.e79_ref4) 2008; 336
The Korean Society of Gynecologic Oncology (10.3346/jkms.2018.33.e79_ref29) 2010
Al-Hameed (10.3346/jkms.2018.33.e79_ref9) 2015; 10
Balshem (10.3346/jkms.2018.33.e79_ref20) 2011; 64
The Korean Academy of Tuberculosis and Respiratory Diseases (10.3346/jkms.2018.33.e79_ref32) 2014
The Korean Society of Neurogastroenterology and Motility (10.3346/jkms.2018.33.e79_ref35) 2012
Alexander (10.3346/jkms.2018.33.e79_ref26) 2014; 67
Seo (10.3346/jkms.2018.33.e79_ref3) 2011; 54
Guyatt (10.3346/jkms.2018.33.e79_ref24) 2008; 336
Alexander (10.3346/jkms.2018.33.e79_ref28) 2016; 70
The Korean Urological Association (10.3346/jkms.2018.33.e79_ref39) 2015
15788089 - BMC Health Serv Res. 2005 Mar 23;5(1):25
15205295 - BMJ. 2004 Jun 19;328(7454):1490
23132890 - Med Care Res Rev. 2013 Feb;70(1 Suppl):80S-93S
25618534 - J Clin Epidemiol. 2016 Apr;72:98-106
19210357 - Allergy. 2009 May;64(5):669-77
22863410 - J Clin Epidemiol. 2013 Feb;66(2):140-50
18467413 - BMJ. 2008 May 10;336(7652):1049-51
23570745 - J Clin Epidemiol. 2013 Jul;66(7):726-35
26772609 - J Clin Epidemiol. 2016 Apr;72:45-55
21241318 - Allergy. 2011 May;66(5):588-95
18436948 - BMJ. 2008 Apr 26;336(7650):924-6
15615589 - BMC Health Serv Res. 2004 Dec 22;4(1):38
26399903 - J Clin Epidemiol. 2016 Feb;70:111-22
18456631 - BMJ. 2008 May 3;336(7651):995-8
23623694 - J Clin Epidemiol. 2013 Jul;66(7):736-42; quiz 742.e1-5
21195583 - J Clin Epidemiol. 2011 Apr;64(4):383-94
24388966 - J Clin Epidemiol. 2014 Jun;67(6):629-34
21208779 - J Clin Epidemiol. 2011 Apr;64(4):401-6
22542023 - J Clin Epidemiol. 2013 Feb;66(2):151-7
16931644 - Am J Respir Crit Care Med. 2006 Sep 1;174(5):605-14
21596725 - Arch Dis Child. 2011 Aug;96(8):723-8
25593601 - Ann Thorac Med. 2015 Jan-Mar;10(1):3-15
23312392 - J Clin Epidemiol. 2013 Jul;66(7):719-25
22406196 - J Clin Epidemiol. 2013 Feb;66(2):124-31
19753107 - PLoS Med. 2009 Sep;6(9):e1000094
18497416 - BMJ. 2008 May 24;336(7654):1170-3
25578218 - J Clin Epidemiol. 2015 Jun;68(6):703-7
References_xml – volume: 72
  start-page: 98
  year: 2016
  ident: 10.3346/jkms.2018.33.e79_ref27
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2014.10.011
– volume: 70
  start-page: 111
  year: 2016
  ident: 10.3346/jkms.2018.33.e79_ref28
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2015.09.006
– volume: 64
  start-page: 401
  issue: 4
  year: 2011
  ident: 10.3346/jkms.2018.33.e79_ref20
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2010.07.015
– volume: 67
  start-page: 629
  issue: 6
  year: 2014
  ident: 10.3346/jkms.2018.33.e79_ref26
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2013.09.020
– volume-title: Korean Clinical Practice Guideline for Colon and Rectal Cancer v.1.0
  year: 2012
  ident: 10.3346/jkms.2018.33.e79_ref31
– volume-title: Revision of the Guidelines for Chronic Obstructive Pulmonary Disease 2014
  year: 2014
  ident: 10.3346/jkms.2018.33.e79_ref32
– volume: 66
  start-page: 726
  issue: 7
  year: 2013
  ident: 10.3346/jkms.2018.33.e79_ref14
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2013.02.003
– volume: 336
  start-page: 1170
  issue: 7654
  year: 2008
  ident: 10.3346/jkms.2018.33.e79_ref24
  publication-title: BMJ
  doi: 10.1136/bmj.39504.506319.80
– volume: 70
  start-page: 80S
  issue: 1
  year: 2013
  ident: 10.3346/jkms.2018.33.e79_ref22
  publication-title: Med Care Res Rev
  doi: 10.1177/1077558712461283
– volume-title: Korean Clinical Practice Guidelines for Common Bile Duct Stones
  year: 2013
  ident: 10.3346/jkms.2018.33.e79_ref37
– volume-title: Revision of the Guidelines for Chronic Obstructive Pulmonary Disease 2012
  year: 2012
  ident: 10.3346/jkms.2018.33.e79_ref30
– volume-title: Cough Guideline
  year: 2014
  ident: 10.3346/jkms.2018.33.e79_ref38
– volume: 336
  start-page: 995
  issue: 7651
  year: 2008
  ident: 10.3346/jkms.2018.33.e79_ref21
  publication-title: BMJ
  doi: 10.1136/bmj.39490.551019.BE
– volume-title: Development and Dissemination of CPGs for Chronic Diseases
  year: 2013
  ident: 10.3346/jkms.2018.33.e79_ref40
– volume: 66
  start-page: 736
  issue: 7
  year: 2013
  ident: 10.3346/jkms.2018.33.e79_ref6
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2013.02.004
– volume-title: Korean Clinical Practice Guideline for Gastric Cancer
  year: 2012
  ident: 10.3346/jkms.2018.33.e79_ref36
– volume-title: Korean Clinical Practice Guideline for Benign Prostate Hyperplasia
  year: 2015
  ident: 10.3346/jkms.2018.33.e79_ref39
– volume-title: Korean Guideline for the Management of Gastroesophageal Reflux Disease
  year: 2012
  ident: 10.3346/jkms.2018.33.e79_ref35
– volume: 66
  start-page: 124
  issue: 2
  year: 2013
  ident: 10.3346/jkms.2018.33.e79_ref8
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2011.12.007
– volume: 68
  start-page: 703
  issue: 6
  year: 2015
  ident: 10.3346/jkms.2018.33.e79_ref7
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2014.11.006
– volume: 174
  start-page: 605
  issue: 5
  year: 2006
  ident: 10.3346/jkms.2018.33.e79_ref11
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200602-197ST
– volume: 336
  start-page: 1049
  issue: 7652
  year: 2008
  ident: 10.3346/jkms.2018.33.e79_ref12
  publication-title: BMJ
  doi: 10.1136/bmj.39493.646875.AE
– volume: 66
  start-page: 140
  issue: 2
  year: 2013
  ident: 10.3346/jkms.2018.33.e79_ref23
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2012.04.012
– volume: 328
  start-page: 1490
  issue: 7454
  year: 2004
  ident: 10.3346/jkms.2018.33.e79_ref16
  publication-title: BMJ
  doi: 10.1136/bmj.328.7454.1490
– volume: 336
  start-page: 924
  issue: 7650
  year: 2008
  ident: 10.3346/jkms.2018.33.e79_ref4
  publication-title: BMJ
  doi: 10.1136/bmj.39489.470347.AD
– volume-title: Korean Guidelines for Asthma, Revised 2014
  year: 2014
  ident: 10.3346/jkms.2018.33.e79_ref33
– volume-title: KASL Clinical Practice Guidelines: Management of Chronic Hepatitis B
  year: 2011
  ident: 10.3346/jkms.2018.33.e79_ref34
– volume: 66
  start-page: 151
  issue: 2
  year: 2013
  ident: 10.3346/jkms.2018.33.e79_ref19
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2012.01.006
– volume: 96
  start-page: 723
  issue: 8
  year: 2011
  ident: 10.3346/jkms.2018.33.e79_ref1
  publication-title: Arch Dis Child
  doi: 10.1136/adc.2010.199307
– volume: 54
  start-page: 758
  issue: 7
  year: 2011
  ident: 10.3346/jkms.2018.33.e79_ref3
  publication-title: J Korean Med Assoc
  doi: 10.5124/jkma.2011.54.7.758
– volume: 10
  start-page: 3
  issue: 1
  year: 2015
  ident: 10.3346/jkms.2018.33.e79_ref9
  publication-title: Ann Thorac Med
  doi: 10.4103/1817-1737.146849
– volume: 5
  start-page: 25
  issue: 1
  year: 2005
  ident: 10.3346/jkms.2018.33.e79_ref5
  publication-title: BMC Health Serv Res
  doi: 10.1186/1472-6963-5-25
– volume-title: Practice Guideline for Gynecologic Cancer Version 2.0
  year: 2010
  ident: 10.3346/jkms.2018.33.e79_ref29
– volume: 66
  start-page: 719
  issue: 7
  year: 2013
  ident: 10.3346/jkms.2018.33.e79_ref13
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2012.03.013
– volume: 66
  start-page: 588
  issue: 5
  year: 2011
  ident: 10.3346/jkms.2018.33.e79_ref15
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2010.02530.x
– volume: 64
  start-page: 669
  issue: 5
  year: 2009
  ident: 10.3346/jkms.2018.33.e79_ref17
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2009.01973.x
– volume: 6
  start-page: e1000094
  issue: 9
  year: 2009
  ident: 10.3346/jkms.2018.33.e79_ref10
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000094
– volume: 64
  start-page: 383
  issue: 4
  year: 2011
  ident: 10.3346/jkms.2018.33.e79_ref18
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2010.04.026
– volume: 4
  start-page: 38
  issue: 1
  year: 2004
  ident: 10.3346/jkms.2018.33.e79_ref2
  publication-title: BMC Health Serv Res
  doi: 10.1186/1472-6963-4-38
– volume: 72
  start-page: 45
  year: 2016
  ident: 10.3346/jkms.2018.33.e79_ref25
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2015.11.017
– reference: 15205295 - BMJ. 2004 Jun 19;328(7454):1490
– reference: 19753107 - PLoS Med. 2009 Sep;6(9):e1000094
– reference: 22542023 - J Clin Epidemiol. 2013 Feb;66(2):151-7
– reference: 16931644 - Am J Respir Crit Care Med. 2006 Sep 1;174(5):605-14
– reference: 23312392 - J Clin Epidemiol. 2013 Jul;66(7):719-25
– reference: 15615589 - BMC Health Serv Res. 2004 Dec 22;4(1):38
– reference: 15788089 - BMC Health Serv Res. 2005 Mar 23;5(1):25
– reference: 22406196 - J Clin Epidemiol. 2013 Feb;66(2):124-31
– reference: 18467413 - BMJ. 2008 May 10;336(7652):1049-51
– reference: 21195583 - J Clin Epidemiol. 2011 Apr;64(4):383-94
– reference: 25593601 - Ann Thorac Med. 2015 Jan-Mar;10(1):3-15
– reference: 18497416 - BMJ. 2008 May 24;336(7654):1170-3
– reference: 19210357 - Allergy. 2009 May;64(5):669-77
– reference: 25578218 - J Clin Epidemiol. 2015 Jun;68(6):703-7
– reference: 18436948 - BMJ. 2008 Apr 26;336(7650):924-6
– reference: 18456631 - BMJ. 2008 May 3;336(7651):995-8
– reference: 23623694 - J Clin Epidemiol. 2013 Jul;66(7):736-42; quiz 742.e1-5
– reference: 22863410 - J Clin Epidemiol. 2013 Feb;66(2):140-50
– reference: 23132890 - Med Care Res Rev. 2013 Feb;70(1 Suppl):80S-93S
– reference: 26772609 - J Clin Epidemiol. 2016 Apr;72:45-55
– reference: 23570745 - J Clin Epidemiol. 2013 Jul;66(7):726-35
– reference: 21596725 - Arch Dis Child. 2011 Aug;96(8):723-8
– reference: 21208779 - J Clin Epidemiol. 2011 Apr;64(4):401-6
– reference: 24388966 - J Clin Epidemiol. 2014 Jun;67(6):629-34
– reference: 26399903 - J Clin Epidemiol. 2016 Feb;70:111-22
– reference: 21241318 - Allergy. 2011 May;66(5):588-95
– reference: 25618534 - J Clin Epidemiol. 2016 Apr;72:98-106
SSID ssj0025523
Score 2.1516511
Snippet A standardized systematic approach to grade evidence and the strength of recommendations is important for guideline users to minimize bias and help interpret...
Background: A standardized systematic approach to grade evidence and the strength of recommendations is important for guideline users to minimize bias and help...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e79
SubjectTerms Original
의학일반
Title Determinants Used to Justify the Strength of Recommendations among Korean Clinical Practice Guidelines
URI https://www.ncbi.nlm.nih.gov/pubmed/29441759
https://www.proquest.com/docview/2002217158
https://pubmed.ncbi.nlm.nih.gov/PMC5809756
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002315226
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Korean Medical Science, 2018, 33(8), , pp.43-55
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9tAFH5ikapeENAFF4iGqpceTDOLtwNCiL0oVQ-NxG3ksWcAJbFp4kjl3_c92wmhijj0YmvkZWR_Y833-b35HsAXY8Nc5WHo24wnvkqz1E-zxPnInlPJOcqierlY70d41Vffb4Pb5-XR7QucLJV2VE-qPx4e_vn9dIwf_BEpTkkRysGIjLd5jM1DGyWrsI7zUkhSrKfmMQXkzqJJt-fcx1laNUHLpXcgi-CEinORhenCfLVajN0yKvpvRuXCFHWxCRstt2QnzWDYghVbbMObXhs9fwfubCH3hfUnNmdVyep6Xu6JIRNkFKMu7qp7VjpGwnQ0sm3RpQmryxKxmxJZZsFaO9Eh-9musmKXUzLMoiT699C_OP91euW3dRb8TMlu5QunchU4Y0wemEwaGwcIlJQopoxVRkkjlM2SQEQ2FMISAxJG8TgVLorS3MkPsFaUhd0BZlVsXJQY3AiVo5hzXYkNI1XXxrmKPPg2e5s6a03IqRbGUKMYISg0QaEJCmxqhMKDr_MrHhsDjlfO_YwA6UH2oMk1m_Z3pR6MNWqDa10703PpwcEMP42fEsVH0sKWU7oTEhocnkHswccGz3mXs-HgQfQC6fkJ1OHLI8XDfW3XHcTdJArCT_995S68pYekXHGe7MFaNZ7afaRClemgCLi-6dQ_Ejr1aP8L28gMIA
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determinants+Used+to+Justify+the+Strength+of+Recommendations+among+Korean+Clinical+Practice+Guidelines&rft.jtitle=Journal+of+Korean+medical+science&rft.au=Shin%2C+Ein-Soon&rft.au=Jang%2C+Ji-Eun&rft.au=Yeon%2C+Ji-Yun&rft.au=Kim%2C+Da-sol&rft.date=2018-02-19&rft.pub=The+Korean+Academy+of+Medical+Sciences&rft.issn=1011-8934&rft.eissn=1598-6357&rft.volume=33&rft.issue=8&rft_id=info:doi/10.3346%2Fjkms.2018.33.e79&rft_id=info%3Apmid%2F29441759&rft.externalDocID=PMC5809756
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon